ClinicalTrials.Veeva

Menu

Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery

G

Guangdong Provincial People's Hospital (Guangdong Provincial Academy of Medical Sciences)

Status

Enrolling

Conditions

Tricuspid Valve Regurgitation; Complications, Longterm Outcome

Treatments

Procedure: Huanlei Huang

Study type

Observational

Funder types

Other

Identifiers

NCT06554119
Guangdong Provincial PHosp

Details and patient eligibility

About

This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.

Enrollment

375 estimated patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery

Exclusion Criteria: age <16,severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.

Trial design

375 participants in 2 patient groups

TVR
Description:
tricuspid valve replacement group,
Treatment:
Procedure: Huanlei Huang
TVP
Description:
tricuspid valvuloplasty group
Treatment:
Procedure: Huanlei Huang

Trial contacts and locations

1

Loading...

Central trial contact

Yingjie Ke; Huanlei Huang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems